Stock Market News

RBC Capital Sees Eli Lilly’s (LLY) Retatrutide as Key Growth Driver despite Mixed Trial Results

wcc wcc
Mar 21, 2026 - 08:10
0 2
RBC Capital Sees Eli Lilly’s (LLY) Retatrutide as Key Growth Driver despite Mixed Trial Results
Previous Article

BMO Capital Raises S&P Global (SPGI) Price Target on Strong Issuance Momentum

Next Article

Bye-Bye, Biden-Era Fiduciary Rule. Here’s What Comes Next

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0
wcc
wcc

Related Posts

Dollar Slips as Lower Crude Prices Ease Rate-Hike Concerns

Dollar Slips as Lower Crude Prices Ease Rate-Hike Co...

wcc
Jun 28, 2026
0
0
Alkami (ALKT) Integrates FDX API With Yodlee for Financial Data Sharing

Alkami (ALKT) Integrates FDX API With Yodlee for Fin...

wcc
Jun 28, 2026
0
0
Nat-Gas Prices Drop as July Nymex Contract Expires

Nat-Gas Prices Drop as July Nymex Contract Expires

wcc
Jun 28, 2026
0
0
3 Altcoins That Could Hit New All-Time Highs This Weekend

3 Altcoins That Could Hit New All-Time Highs This We...

wcc
Jun 28, 2026
0
0
This Biotech ETF Has Almost Doubled in 13 Months. Money Is Flowing In.

This Biotech ETF Has Almost Doubled in 13 Months. Mo...

wcc
Jun 28, 2026
0
0
Cashing Out: How Basel III and High Rates Triggered the Great Selloff in Gold Prices

Cashing Out: How Basel III and High Rates Triggered ...

wcc
Jun 28, 2026
0
0

Comments (0)

User